Venture capitalists, private equity investors, big pharma, foundations, licensing executives, investment bankers and emerging companies from around the nation will converge at the 14th Annual Biotech Investing Conference, November 8, 2006 in Menlo Park, CA to share their unique perspectives and strategies on the latest initiatives in bio investing from an early, mid and later stage prospective.

The 14th Annual Biotech Investing Conference, November 8, 2006 being held at SRI International is a program to keep venture investors informed of emerging trends in the biotech sector, as well as investing strategies and collaborative business opportunities. In addition, the conference will also provide big pharma's perspective on rebuilding the pipeline and a look at how foundations are becoming a tool to fund early-stage research.

This year's conference sponsors include: SRI International, ABD Insurance Services Financial, GE Healthcare Financial Services Life Science Finance, and Charter Life Sciences.

This is cache, read story here